A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudden vision loss. The study, based on millions of FDA side-effect reports, found the risk signal was nearly five times stronger for Wegovy than for Ozempic, despite both containing semaglutide.
The condition, called ischemic optic neuropathy (ION), occurs when blood flow to the optic nerve is reduced or blocked. This can cause sudden partial or complete blindness in one or both eyes.
Researchers reported that Wegovy showed the strongest ass... [5055 chars]